Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
When To Use Index Funds With Active Funds
Using index funds with active funds works best in markets with clear diversification needs and where costs and risk management matter most.
21,614 articlesAGNC Investment's Interest Spread Outweighs Its 14% Yield
Income-focused investors flock to AGNC for its big dividend, but the real driver of long-term value is its net intere...
Stock Market Today: Super Micro Jumps on Compliance Win
In today’s stock market today recap, Super Micro Computer surged after news of export-compliance collaboration. Inves...
That Didn't Take Long: Warsh Takes Fed Chair Spotlight
When headlines shift at the Fed, markets tend to move fast. This piece breaks down how Warsh becoming Fed Chair could...
Prediction: Spacex Will Greatest IPO Fleece Risk for Retail
SpaceX IPO chatter has investors buzzing and critics worried. This piece breaks down why the hype could outpace reali...
Apple’s Could Usher Historic Upgrade Cycle, Markets React
Apple is steering its AI push toward a hardware-driven revenue surge, potentially triggering a historic upgrade cycle...
Three Stocks with Yield Over 6% Shine Amid Market Turbulence
With market volatility on the rise, investors are turning to high-yield dividend plays. Three U.S. names stand out fo...
Bask Bank Review: Is It the Right Savings Option for You?
Bask Bank offers a trio of online savings paths with no branches or debit card: cash yields, airline miles, and fixed...
Mission Produce Director Buys: Is AVO Stock Ready?
A Mission Produce director just bought a multi-million-dollar stake in AVO. This article breaks down what insider buy...
USDT Gets Brazil Payment Route to 170 Million People
A Brazil fintech quietly links USDT to the Pix payments rail, creating a behind-the-scenes bridge that could redefine...
Could Research Next Trillion: Lam Research's AI Infrastructure Edge
Lam Research sits at the core of AI infrastructure tooling. This article explores whether the company could research ...
Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status